VGM Meets with CMS to Discuss Concerns Related to Post-PHE

Published in Government Relations on March 28, 2022

VGM Government Relations recently met with CMS to discuss concerns about supplier requirements once the public health emergency (PHE) comes to an end.

We heard your concerns related to policy requirements and expectations after the PHE comes to an end and brought those to the attention of Provider Compliance Group for CMS’ Program Integrity. The discussion included a number of topics including providing plenty of notice (60 to 90 days) to the healthcare industry in preparation prior to the end of the PHE.

In addition, the discussion included concerns for the patients that are currently renting DME under the PHE waivers. Will these patients need to get qualified to meet policy coverage criteria, or will these patients fall under the grandfather method? While CMS representatives could not provide details, there was agreement that disruption of equipment use, medical necessity, and reimbursement should not occur for the patients and the suppliers.

Amongst the discussion, VGM’s Ronda Buhrmester and U.S. Rehab’s Dan Fedor raised concerns related to audits. With the various contractors that audit CMS claims, it was important that CMS is aware of the scrutiny that tends to fall on the DME suppliers. The claims using a PHE waiver (using the CR modifier and COVID-19 claim narrative) are a big concern for suppliers. The suppliers were also on the front lines collaborating with hospitals, nursing facilities, and physician clinics offering services to keep patients safe in their homes using home medical equipment.

While there were several topics of discussion related to policies and audits for post PHE, VGM’s Mark Higley provided data-related increases in staffing/wages, as well as acquisition costs.

The CMS staff appreciated the informative conversation with VGM, and are looking forward to future communications between both parties.


TAGS

  1. billing & reimbursement
  2. cms
  3. dmepos
  4. regulatory
  5. reimbursement
  6. vgm
  7. vgm government

From Our Experts

Alabama Durable Medical Equipment Association (ADMEA) Seeks New Executive Director thumbnail Alabama Durable Medical Equipment Association (ADMEA) Seeks New Executive Director The Alabama Durable Medical Equipment Association (ADMEA) is now accepting applications for the role of Executive Director. This is an exciting leadership opportunity for an individual with a passion for healthcare, industry advocacy, and association management. 2025 CMS Proposed Rule Challenges and To-Dos thumbnail 2025 CMS Proposed Rule Challenges and To-Dos The 2025 CMS Proposed Rule for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) introduces several significant changes that present both operational and financial challenges for DME companies. You Got the Contract! …NOW WHAT?! A Short Series thumbnail You Got the Contract! …NOW WHAT?! A Short Series Congratulations! You FINALLY got the contract you've been working so hard on all these months. Now that you have it, what are the critical next steps you need to take to maintain and implement the contract and generate ROI? Welcome to the first of a short series of articles to help you accomplish just that. NAAOP Hosts First Ever In-Person Legislative Fly-In thumbnail NAAOP Hosts First Ever In-Person Legislative Fly-In Last week, 33 stakeholders, advocates, and leaders from around the O&P industry convened at the offices of Powers Pyles Sutter & Verville PC in Washington, D.C., as part of The National Association for the Advancement of Orthotics and Prosthetics's (NAAOP) first ever in-person legislative fly-in. Co-sponsored by OPGA, the fly-in kicked off with an in-depth discussion and strategy session surrounding several legislative priorities affecting O&P providers and patients. VGM Government Relations Unveils Grassroots Advocacy Toolkit to Empower DME Champions of Change thumbnail VGM Government Relations Unveils Grassroots Advocacy Toolkit to Empower DME Champions of Change The VGM Government Relations team is proud to announce the launch of its Grassroots Advocacy Toolkit, thoughtfully crafted to support durable medical equipment (DME) professionals, caregivers, industry partners, and patient advocates in advancing legislative initiatives that impact home medical equipment and services. Featuring Two Champions Of Change: Robert Beard of YD Home Medical & Rob Minicucci Jr. of Health System Services thumbnail Featuring Two Champions Of Change: Robert Beard of YD Home Medical & Rob Minicucci Jr. of Health System Services Today, we're proud to spotlight two outstanding durable medical equipment (DME) champions whose advocacy efforts are making a meaningful difference: Robert Beard of YD Home Medical of Alabama and Rob Minicucci Jr. of Health System Services of New York. These individuals took time out of their busy schedules to personally connect with elected officials, demonstrating how local action can spark national change. Survey: Share Your Thoughts on Proposed Accreditation Rule Changes thumbnail Survey: Share Your Thoughts on Proposed Accreditation Rule Changes CQRC, VGM, and AAHomecare are requesting your feedback on a new proposed rule that could significantly impact accreditation procedures. Under the proposal, accreditation organizations would be required to conduct site visits every year—a major shift from the current once-every-three-years schedule. WEBINAR: Navigating New CMS Guidelines: Unlocking Opportunities in NIPPV and RAD Coverage for COPD Care thumbnail WEBINAR: Navigating New CMS Guidelines: Unlocking Opportunities in NIPPV and RAD Coverage for COPD Care The Centers for Medicare & Medicaid Services (CMS) has revised the NCD for Noninvasive Positive Pressure Ventilation (NIPPV) in the home setting for treating Chronic Respiratory Failure (CRF) due to Chronic Obstructive Pulmonary Disease (COPD). The changes aim to establish clear coverage policies for devices such as Respiratory Assist Devices (RADs) and home mechanical ventilators (HMVs), potentially expanding access to these critical therapies for eligible patients. Adapting to new CMS guidelin